Prescription drug cost sharing: associations with medication and medical utilization and spending and health
ContextPrescription drugs are instrumental to managing and preventing chronic disease.
Recent changes in US prescription drug cost sharing could affect access to them …
Recent changes in US prescription drug cost sharing could affect access to them …
The role of protein digestibility and antacids on food allergy outcomes
E Untersmayr, E Jensen-Jarolim - Journal of Allergy and Clinical …, 2008 - Elsevier
Digestion assays with simulated gastric fluid have been introduced for characterization of
food proteins to imitate the effect of stomach proteolysis on dietary compounds in vitro. By …
food proteins to imitate the effect of stomach proteolysis on dietary compounds in vitro. By …
What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries
MC Gemmill, S Thomson, E Mossialos - International journal for equity in …, 2008 - Springer
As pharmaceutical expenditure continues to rise, third-party payers in most high-income
countries have increasingly shifted the burden of payment for prescription drugs to patients …
countries have increasingly shifted the burden of payment for prescription drugs to patients …
Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies
A Acosta, A Ciapponi, M Aaserud… - Cochrane Database …, 2014 - cochranelibrary.com
Background Pharmaceuticals are important interventions that could improve people's health.
Pharmaceutical pricing and purchasing policies are used as cost‐containment measures to …
Pharmaceutical pricing and purchasing policies are used as cost‐containment measures to …
Benefits and risks of increasing restrictions on access to costly drugs in Medicaid
SB Soumerai - Health Affairs, 2004 - healthaffairs.org
States are reacting to increased Medicaid drug costs by implementing cost-control policies,
such as preferred drug lists (PDLs) and prior authorization. PDLs have risks as well as …
such as preferred drug lists (PDLs) and prior authorization. PDLs have risks as well as …
Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experiment
S Schneeweiss, AR Patrick, M Maclure, CR Dormuth… - Circulation, 2007 - Am Heart Assoc
Background—As medication spending grows, Medicare Part D will need to adapt its
coverage policies according to emerging evidence from a variety of insurance policies. We …
coverage policies according to emerging evidence from a variety of insurance policies. We …
Effects of reference pricing in pharmaceutical markets: a review
MM Galizzi, S Ghislandi, M Miraldo - Pharmacoeconomics, 2011 - Springer
This work aims to provide a systematic and updated survey of original scientific studies on
the effect of the introduction of reference pricing (RP) policies in Organisation for Economic …
the effect of the introduction of reference pricing (RP) policies in Organisation for Economic …
Pharmaceutical policies: effects of restrictions on reimbursement
CJ Green, M Maclure, PM Fortin… - Cochrane Database …, 1996 - cochranelibrary.com
Background Public policy makers and benefit plan managers need to restrain rising
pharmaceutical drug costs while preserving access and optimizing health benefits …
pharmaceutical drug costs while preserving access and optimizing health benefits …
Impact of two sequential drug cost-sharing policies on the use of inhaled medications in older patients with chronic obstructive pulmonary disease or asthma
CR Dormuth, RJ Glynn, P Neumann, M Maclure… - Clinical …, 2006 - Elsevier
BACKGROUND:: Evaluations of drug cost-sharing policies within the same population are
needed for a fair comparison of different options. OBJECTIVE:: The aim of this work was to …
needed for a fair comparison of different options. OBJECTIVE:: The aim of this work was to …
Pharmaceutical pricing and reimbursement policies in Canada
V Paris, É Docteur - 2007 - papers.ssrn.com
This paper describes and assesses pharmaceutical pricing and reimbursement policies in
Canada, considering them in the context of the broader policy and market environment in …
Canada, considering them in the context of the broader policy and market environment in …